Clinical trials
Phase 4 trials in Slovenia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 6 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 8 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 62 |
| Unknown status | 6 |
| Recruiting | 5 |
| Terminated | 5 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Medical Centre Ljubljana | 36 |
| Hoffmann-La Roche | 5 |
| Novartis Pharmaceuticals | 3 |
| Novo Nordisk A/S | 3 |
| Astellas Pharma Europe Ltd. | 2 |
| Boehringer Ingelheim | 2 |
| Eli Lilly and Company | 2 |
| General and Teaching Hospital Celje | 2 |
| GlaxoSmithKline | 2 |
| KRKA | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 9 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 5 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Diabetes Mellitus, Type 1 | 3 |
| Hemophilia A | 3 |
| Insulin Resistance | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Critical Illness | 2 |
| Glossitis, Benign Migratory | 2 |
Trials
Showing 76 to 81 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.